Home » Topics » BioWorld Science

BioWorld Science
RSS

New use for 5-HT2 antagonist

Sep. 20, 1996

Troglitazone nearing launch

Sep. 20, 1996

New indications discovered for Ligand's retinoid compound, Targretin

Sep. 20, 1996

Clinical trials with Gilead Sciences' GS-840

Sep. 20, 1996

Prokinetic macrolides reported by Abbott

Sep. 20, 1996

Second pivotal trial for Carrington's ulcerative colitis product

Sep. 20, 1996

Novel proton pump inhibitors from Dainippon

Sep. 20, 1996

NC-1800 advances through clinical trials

Sep. 20, 1996

New agents for BPH from Abbott

Sep. 20, 1996

Merck & Co. continues to investigate 5alpha-reductase inhibitors

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...